Michael J. Ross, M.D.

Medicine

Phone718-430-8768
Emailmichael.ross@einstein.yu.edu
Websitehttp://www.einstein.yu.edu/faculty/15329/michael-ross/

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education/Academic qualification

Mount Sinai School Medicine

1998 → 2001

Duke University Medical Center

1995 → 1998

NYU School of Medicine

1991 → 1995

Tufts University

1987 → 1991

Keywords

R Medicine (General)
QR355 Virology
Q Science (General)

Fingerprint

Dive into the research topics where Michael J. Ross is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

14 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

5 Finished

The role of APOL1 polymorphisms in promoting HIV-related kidney injury
Ross, M. J.
National Institute of Diabetes and Digestive and Kidney Diseases
9/25/15 → 6/30/16
Project: Research project
Novel mechanisms of antiretroviral protection against HIV-related kidney diseases
Ross, M. J.
National Institute of Diabetes and Digestive and Kidney Diseases
9/15/14 → 6/30/15
Project: Research project
The role of FAT10 in the pathogenesis of HIV-associated nephropathy
Ross, M. J.
National Institute of Diabetes and Digestive and Kidney Diseases
8/15/07 → 7/31/08
Project: Research project
FAT10 a candidate gene for epithelial apoptosis in HIV-associated nephropathy
Ross, M. J.
National Institute of Diabetes and Digestive and Kidney Diseases
5/1/07 → 4/30/08
Project: Research project
Epithelial gene expression in HIV-associated nephropathy
Ross, M. J.
National Institute of Diabetes and Digestive and Kidney Diseases
9/30/05 → 9/29/06
Project: Research project

3825 Citations
27 h-Index
41 Article
11 Comment/debate
11 Review article
4 Editorial
5 More

Publisher Correction: The HIV protease inhibitor darunavir prevents kidney injury via HIV-independent mechanisms (Scientific Reports, (2019), 9, 1, (15857), 10.1038/s41598-019-52278-3)
Gao, X., Rosales, A., Karttunen, H., Bommana, G. M., Tandoh, B., Yi, Z., Habib, Z., D’Agati, V., Zhang, W. & Ross, M. J., Dec 1 2020, In : Scientific reports. 10, 1, 4345.
Research output: Contribution to journal › Comment/debate

Open Access
Rationale and design of the Transformative Research in Diabetic Nephropathy (TRIDENT) Study
Townsend, R. R., Guarnieri, P., Argyropoulos, C., Blady, S., Boustany-Kari, C. M., Devalaraja-Narashimha, K., Morton, L., Mottl, A. K., Patel, U., Palmer, M., Ross, M. J., Sarov-Blat, L., Steinbugler, K., Susztak, K., Luciano, R., Ross, M., Canetta, P., Campbell, K., Hogan, J., Mottl, A. & 10 others, Lenz, O., Szerlip, H., Bansal, S., Brosius, C., Schelling, J., Almaani, S., Kretzler, M., Isakova, T., Avasare, R. & Lafayette, R., Jan 2020, In : Kidney international. 97, 1, p. 10-13 4 p.
Research output: Contribution to journal › Editorial

2 Scopus citations
Ritonavir-Boosted Protease Inhibitors Do Not Significantly Affect the Performance of Creatinine-Based Estimates of GFR
Wyatt, C. M., Chaudhari, J., Miao, S., Krishnasami, Z., Hellinger, J., Levey, A. S., Ross, M., Ryom, L., Mocroft, A., Brunet, L., Fusco, J. & Inker, L. A., May 2020, In : Kidney International Reports. 5, 5, p. 734-737 4 p.
Research output: Contribution to journal › Article

Open Access
The feasibility and safety of obtaining research kidney biopsy cores in patients with diabetes an interim analysis of the trident study
TRIDENT Study Investigators, Jul 2020, In : Clinical Journal of the American Society of Nephrology. 15, 7, p. 1024-1026 3 p.
Research output: Contribution to journal › Letter
New Insights into APOL1 and Kidney Disease in African Children and Brazilians Living With End-Stage Kidney Disease
Ross, M. J., Jul 2019, In : Kidney International Reports. 4, 7, p. 908-910 3 p.
Research output: Contribution to journal › Editorial

Open Access

1 Scopus citations